We are live on ! Find out more
SFM

Sphera Funds Management Portfolio holdings

AUM $630M
1-Year Est. Return 108.65%
This Fund
S&P 500
This Quarter Est. Return
-0.86%
1 Year Est. Return
+108.65%
3 Year Est. Return
+217.64%
5 Year Est. Return
+342.91%
10 Year Est. Return
+2,254.45%
AUM
$1.19B
AUM Growth
-$288M
Cap. Flow
-$155M
Cap. Flow %
-13.04%
Top 10 Hldgs %
42.35%
Holding
170
New
36
Increased
27
Reduced
26
Closed
54

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$49M
2
LLY icon
Eli Lilly
LLY
+$41.1M
3
ABBV icon
AbbVie
ABBV
+$26.3M
4
PANW icon
Palo Alto Networks
PANW
+$13.1M
5
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$11.8M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$60.1M
2
JNJ icon
Johnson & Johnson
JNJ
+$28.4M
3
GNRC icon
Generac Holdings
GNRC
+$14.3M
4
LPSN icon
LivePerson
LPSN
+$14.2M
5
AMZN icon
Amazon
AMZN
+$13.5M

Sector Composition

Rank Sector Weight
1 Healthcare 63.14%
2 Technology 10.82%
3 Industrials 3.99%
4 Financials 3.13%
5 Communication Services 1.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VRNS icon
151
Varonis Systems
VRNS
$4.59B
– –
-218,013
Closed -$12.6M
WIX icon
152
WIX.com
WIX
$2.3B
– –
-5,700
Closed -$1.66M
XLK icon
153
PUT
State Street Technology Select Sector SPDR ETF
XLK
$115B
– –
-420,000
Closed -$31M
MSPR
154
DELISTED
MSP Recovery Inc
MSPR
– –
-23
Closed -$986K
ONC
155
BeOne Medicines Ltd
ONC
$32.8B
– –
-20,900
Closed -$7.17M
CERE
156
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
– –
-9,212
Closed -$236K
OMIC
157
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
– –
-1,796
Closed -$1.48M
GRCL
158
DELISTED
Gracell Biotechnologies Inc. American Depositary Shares
GRCL
– –
-233,850
Closed -$3.04M
ORTX
159
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
– –
-136,656
Closed -$6M
MRTX
160
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
– –
-47,309
Closed -$7.64M
SGTX
161
DELISTED
Sigilon Therapeutics, Inc. Common Stock
SGTX
– –
-27,711
Closed -$3.87M
TWNI.U
162
DELISTED
Tailwind International Acquisition Corp. Units, each consisting of one Class A ordinary share and one-third of one redeemable warrant
TWNI.U
– –
-48,342
Closed -$483K
CLRMU
163
DELISTED
Clarim Acquisition Corp. Unit
CLRMU
– –
-148,886
Closed -$1.48M
LFTR
164
DELISTED
Lefteris Acquisition Corp. Class A Common Stock
LFTR
– –
-114,428
Closed -$1.12M
ETAC
165
DELISTED
E.Merge Technology Acquisition Corp. Class A Common Stock
ETAC
– –
-100,000
Closed -$976K
HCCCU
166
DELISTED
Healthcare Capital Corp. Unit
HCCCU
– –
-196,610
Closed -$1.96M
HCAQ
167
DELISTED
HealthCor Catalio Acquisition Corp. Class A Ordinary Shares
HCAQ
– –
-200,000
Closed -$1.97M
CEREW
168
DELISTED
Cerevel Therapeutics Holdings, Inc. Warrant
CEREW
– –
-165,295
Closed -$2.38M
3 4 5 6
7

Similar funds

VIM
Vancity Investment Management Vancouver, British Columbia, Canada $629M AUM 2.49% 1-Year Est. Return
KCMH
Keywise Capital Management (HK) Hong Kong $630M AUM 81.01% 1-Year Est. Return
FCFC
First Commonwealth Financial Corp Indiana, Pennsylvania $629M AUM 20.47% 1-Year Est. Return
BI
BlueSpruce Investments Chicago, Illinois $631M AUM 11.83% 1-Year Est. Return
PWW
Pettyjohn Wood & White Lynchburg, Virginia $628M AUM 20.96% 1-Year Est. Return
TTSTC
Texas Treasury Safekeeping Trust Company Austin, Texas $628M AUM 15.58% 1-Year Est. Return
SWP
Summit Wealth Partners Orlando, Florida $632M AUM 9.71% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return

Sphera Funds Management's Q3 2021 Portfolio in Review

As of Q3 2021, Sphera Funds Management held 170 positions worth $1.19B, down 19% from $1.48B the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Sphera Funds Management withdrew a net $155M in Q3 2021, closing 54 positions and reducing 26 holdings. Its most notable exit was Merck, an estimated $60.1M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 63% of assets, up from 55% a quarter earlier, followed by Technology and Industrials.

Against the trend, Sphera Funds Management opened a new position in Pfizer worth $47.6M.

  • Sphera Funds Management's largest Q3 2021 buy was Pfizer: 1,106,528 shares worth $47.6M.
  • Sphera Funds Management added most to Eli Lilly in Q3 2021, an estimated $41.1M increase.
  • Sphera Funds Management's biggest Q3 2021 reduction was Johnson & Johnson, cutting an estimated $28.4M.
  • Sphera Funds Management fully exited Merck in Q3 2021, selling an estimated $60.1M.
  • Sphera Funds Management's ten largest holdings make up 42% of its $1.19B portfolio in Q3 2021.
  • Sphera Funds Management opened 36 new positions and closed 54 in Q3 2021.
  • Sphera Funds Management's portfolio value fell 19% quarter-over-quarter to $1.19B.

Based on Sphera Funds Management's 13F filing for Q3 2021, filed 15 Nov 2021.